Search research articles
Contact Us
Filters
Showing results (51-60 of 141) with videos related to
Page
of 15
Sort By:
Vaccine
|
July 14, 2021
Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery
Mellissa Gomez, Joseph McCollum, Hui Wang, et al.
Nature Communications
|
January 28, 2022
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
Audrey Lee, Madeleine K D Scott, Florian Wimmers, et al.
Vaccine
|
October 15, 2013
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses
Christopher B Fox, Magdalini Moutaftsi, Julie Vergara, et al.
Journal of Pharmaceutical Sciences
|
January 28, 2014
Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity
Quinton M Dowling, Sandra J Sivananthan, Jeff A Guderian, et al.
Influenza and Other Respiratory Viruses
|
November 6, 2012
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
Christopher B Fox, Lucien Barnes V, Tara Evers, et al.
Journal of Nanobiotechnology
|
April 29, 2014
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
Christopher B Fox, Sandra J Sivananthan, Malcolm S Duthie, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 30, 2019
Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family
Christopher B Fox, Neal Van Hoeven, Brian Granger, et al.
NPJ Vaccines
|
February 18, 2025
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant
Farha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Enhanced immunogenicity of a <i>Clostridioides difficile</i> TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant
Farha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Journal of Nanobiotechnology
|
December 24, 2013
Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
H W Millie Fung, Traci J T Mikasa, Julie Vergara, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 141) with videos related to
Sort By:
Page
of 15
Vaccine
|
July 14, 2021
Evaluation of the stability of a spray-dried tuberculosis vaccine candidate designed for dry powder respiratory delivery
Mellissa Gomez, Joseph McCollum, Hui Wang, et al.
Nature Communications
|
January 28, 2022
A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
Audrey Lee, Madeleine K D Scott, Florian Wimmers, et al.
Vaccine
|
October 15, 2013
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses
Christopher B Fox, Magdalini Moutaftsi, Julie Vergara, et al.
Journal of Pharmaceutical Sciences
|
January 28, 2014
Modulating potency: Physicochemical characteristics are a determining factor of TLR4-agonist nanosuspension activity
Quinton M Dowling, Sandra J Sivananthan, Jeff A Guderian, et al.
Influenza and Other Respiratory Viruses
|
November 6, 2012
Adjuvanted pandemic influenza vaccine: variation of emulsion components affects stability, antigen structure, and vaccine efficacy
Christopher B Fox, Lucien Barnes V, Tara Evers, et al.
Journal of Nanobiotechnology
|
April 29, 2014
A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7
Christopher B Fox, Sandra J Sivananthan, Malcolm S Duthie, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|
August 30, 2019
Vaccine adjuvant activity of emulsified oils from species of the Pinaceae family
Christopher B Fox, Neal Van Hoeven, Brian Granger, et al.
NPJ Vaccines
|
February 18, 2025
Enhanced immunogenicity of a Clostridioides difficile TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant
Farha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2024
Enhanced immunogenicity of a <i>Clostridioides difficile</i> TcdB vaccine adjuvanted with a synthetic dual-TLR ligand adjuvant
Farha Naz, Nicholas Hagspiel, Feifan Xu, et al.
Journal of Nanobiotechnology
|
December 24, 2013
Optimizing manufacturing and composition of a TLR4 nanosuspension: physicochemical stability and vaccine adjuvant activity
H W Millie Fung, Traci J T Mikasa, Julie Vergara, et al.
Page
of 15